Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apixaban”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Testing effectiveness (Phase 2)Study completedNCT04218266
What this trial is testing

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Who this might be right for
Atrial Fibrillation (AF)
Bayer 755
Large-scale testing (Phase 3)Study completedNCT01780987
What this trial is testing

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Pfizer 80
Early research (Phase 1)Looking for participantsNCT07024160
What this trial is testing

Phase I Study of MT1011 Injection in Healthy Subjects

Who this might be right for
Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT02749617
What this trial is testing

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma

Who this might be right for
Anti-Xa Activity
University of British Columbia 2
Large-scale testing (Phase 3)Ended earlyNCT03839355
What this trial is testing

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Mayo Clinic 34
Not applicableStudy completedNCT05321810
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 193,565
Testing effectiveness (Phase 2)Ended earlyNCT03200613
What this trial is testing

Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesVenous Thromboembolism
McMaster University 8
Not applicableStudy completedNCT02339818
What this trial is testing

Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

Who this might be right for
Stroke, Systemic Embolism, VTEt and VTEp
Bristol-Myers Squibb 126
Testing effectiveness (Phase 2)Ended earlyNCT04593784
What this trial is testing

Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults

Who this might be right for
Healthy
AMAG Pharmaceuticals, Inc. 41
Not applicableStudy completedNCT03182218
What this trial is testing

Periprocedural Direct Oral Anticoagulant Management

Who this might be right for
Periprocedural Complication
Fundación para la Investigación del Hospital Clínico de Valencia 1,100
Large-scale testing (Phase 3)Active Not RecruitingNCT04007289
What this trial is testing

Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension

Who this might be right for
Intrahepatic Non Cirrhotic Portal Hypertension
Assistance Publique - Hôpitaux de Paris 166
Early research (Phase 1)Study completedNCT04278729
What this trial is testing

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous Nephropathy
University of North Carolina, Chapel Hill 22
Not applicableStudy completedNCT04435418
What this trial is testing

Eliquis Acute Stroke Safety Evaluation

Who this might be right for
Ischemic StrokeTransient Ischemic AttackAtrial Fibrillation
University of Alberta 100
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Early research (Phase 1)Study completedNCT04191928
What this trial is testing

Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerDVTPulmonary Embolism
Thomas Jefferson University 4
Not applicableStudy completedNCT03854149
What this trial is testing

Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

Who this might be right for
Congenital Heart DiseaseAtrial ArrhythmiaThromboembolism+1 more
AHEPA University Hospital 218
Large-scale testing (Phase 3)Not Yet RecruitingNCT05687448
What this trial is testing

DIrect Oral Anticoagulation and Bioprothesis Aortic Valve

Who this might be right for
Aortic Valve Disease
Assistance Publique - Hôpitaux de Paris 1,500
Early research (Phase 1)Study completedNCT02599532
What this trial is testing

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeProteinuria
University of North Carolina, Chapel Hill 21
Post-approval studies (Phase 4)Not Yet RecruitingNCT06486792
What this trial is testing

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

Who this might be right for
StrokeIschemic StrokeCerebral Infarction+1 more
Assistance Publique - Hôpitaux de Paris 1,148
Not applicableUnknownNCT02840201
What this trial is testing

Sub-Clinical Atrial Fibrillation Biomarker Study

Who this might be right for
Subclinical Atrial Fibrillation
Ottawa Heart Institute Research Corporation 700
Load More Results